Keren Winmill

Chief Executive Officer and Board Member

Keren Winmill obtained her degree in Pharmacy from the University of Wales in 1975, qualifying as a pharmacist in 1976. Keren initially worked with the Technical Secretariat to the Committee on Safety of Medicines, and then, after 10 years in various Regulatory Affairs and Marketing roles at Ciba Geigy in Switzerland and the UK, she joined Penn Pharmaceuticals in 1990 to build the new clinical supplies group, later becoming Business Development Director. After a period at Quintiles, Scotland, as Business Development Director, she returned to Penn as Director of Clinical Supplies and latterly the Director of Pharmaceutical Services. Prior to joining Biotec in May 2009, Keren acted as an independent consultant, working with several leading pharmaceutical companies

Business Development and Project Management

Dr Fiona Withey

Business Development Director and Board Member

Fiona gained a BSc in Biology and Chemistry followed by a PhD in Biochemical Engineering from the University of Wales, Swansea. Prior to joining Biotec, Fiona began her career as a Senior Scientist in research and development before gaining 10 years experience in various Business Development roles within the healthcare industry. In her current role she is responsible for Business Development, Marketing and Project Management at Biotec.

Dr Matthew Lakelin

Business Development Manager

Matthew joined the Biotec team in January 2008 as a Business Development Manager. Following a degree and PhD in pharmacology from the University of Wales, Cardiff and post doctoral research, Matthew joined Ortho-Clinical Diagnostics as a Validation Scientist. This was followed by 3 years in client facing roles within the Business Development department at Penn Pharmaceutical Services.

Sarah Coram

Clinical Services Manager

Sarah joined Biotec in 2008 after a 14 year career at Penn Pharmaceutical Services, most latterly as Senior Project Manager. In her role as Clinical Services Manager, Sarah has responsibility for proposal development, technical support and client liaison. She holds a first degree in Pharmacology and an MSc in Clinical Research from Cardiff University.

Ed Lewis

Head of Project Management

Ed joined Biotec in February 2009 as a Senior Project Manager having previously been employed by Penn Pharmaceuticals as a Project Manager. A graduate of the University of Gloucestershire, Ed’s career began in Business Development. He has since gained over 10 years strong commercial experience in Marketing Management, Account Management and Project Management. Ed is a client champion whose role within Biotec in to ensure the continued successful delivery of clinical trial projects.

Marina Rees

Project Manager

Marina joined Biotec in January 2010 as a Project Manager. Having worked in various fields in the pharmaceutical industry for over 15 years gaining experience in GMP. GCP and regulatory guidelines. Marina was previously employed with a Phase 1 accredited CRO where she was involved in the set up and execution of clinical studies for global clients.

Operations

Rachel Griffiths

Operations Director and Board Member

Rachel joined Biotec in 2004, following roles as a Development Scientist, Technical Support Scientist and Product Support Specialist at Ortho Clinical Diagnostics. In her role as Director of Operations at Biotec, Rachel has overall responsibility for production and the warehouse. Rachel also holds a degree in microbiology and virology from Warwick University.

Jeremy Martin

Planning Manager

Jeremy joined Biotec in 2000 as Warehouse and Logistics Manager. Prior to his current position of Planning Manager, Jeremy spent 15 years with Amersham, Kodak, Johnson and Johnson and Ortho Clinical Diagnostics most latterly as Logistics and Materials Manager. Jeremy holds a degree in Maritime Science and is a member of the Institute of Logistics and Institute of Production Control. Jeremy has responsibility for project scheduling and logistics project planning across the company

Quality Assurance

Tristram Evans

Quality Assurance

After graduating with a Chemistry degree from University of Wales, Cardiff, Tristram joined Penn Pharmaceuticals as a Quality Control Analyst. This was followed by the position of Quality Assurance Auditor at Norgine where he gained a wealth of experience performing audits to ensure GMP compliance. Tristram subsequently joined Biotec in 2007 as the Quality Assurance Manager.

Marc Weinzweig

Qualified Person and Board Member

Marc has obtained over 25 years experience in regulatory, development, manufacture and testing within the pharmaceutical industry. Marc founded Biotec following a 13 year career with Amersham, Kodak and Johnson & Johnson where he held various positions most latterly as Business Process Improvement Manager. Marc has extensive experience with FDA and European Quality System Regulations and is a registered European Qualified Person (QP) and a member of both the Institute of Biology and the QP Association.

Brian Williams

Qualified Person

Brian is a qualified Pharmacist and Chemical Engineer with over 40 years experience in the pharmaceutical industry, working for the Wellcome Foundation, Cyanamid, Warner Lambert-Parke Davis and Merck Sharp and Dohme. For the last 20 years he has worked for Bayer in a number of roles, including both the positions of Production and QA Directors.

Brian has been a QP since its inception in 1980 and was the Bayer QP and Responsible Person until 2002. He has also experience working in community and hospital pharmacy.

Brian is a Chartered Engineer and a Member of the Institute of Chemical Engineers and the Royal Pharmaceutical Society. He joined Biotec in 2002 as a Qualified Person and quality consultant.

Finance

Ravi Nalliah

Finance Director and Board Member

Ravi joined Biotec in 2009 after more than 10 years in practice, 5 of which was spent specialising in Corporate Finance. In his position as Finance Director, Ravi has overall responsibility for the Finance and Health, Safety and Environmental functions at Biotec. He is a member of the Institute of Chartered Accountants in England and Wales (“ICAEW”). Ravi also holds a Diploma in Corporate Finance from the ICAEW in addition to a BSc in Biochemistry with Molecular Biology from the University of Wales, Cardiff.

[back to about us]